Sign in
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Sunday, September 8, 2024
Sign in / Join
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Facebook
Instagram
Twitter
Vimeo
Youtube
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Reviews
Regulations
Product Reviews
Service Reviews
About Us
Search
Trending Now
Regulatory Update — Week of Sept. 2, 2024
Judge orders J&J to pay Auris investors more than $1B for merger violations
Cloud moment – PharmaTimes
Regulations
Regulatory Update — Week of Sept. 2, 2024
propharmanews
-
September 7, 2024
BioPharma
Judge orders J&J to pay Auris investors more than $1B for merger violations
Pharmaceuticals
Cloud moment – PharmaTimes
Pharmaceuticals
European Commission grants orphan drug designation for Vivet’s VTX-806
Don't Miss
Regulations
Regulatory Update — Week of Sept. 2, 2024
propharmanews
-
September 7, 2024
0
Drugs Devices Columns Regulatory UpdateThis week, the FDA published eight medical device classifications — cardiovascular, dental (2), hematology and pathology, neurologic, ophthalmic, orthopedic and...
Judge orders J&J to pay Auris investors more than $1B for merger violations
September 7, 2024
Cloud moment – PharmaTimes
September 6, 2024
European Commission grants orphan drug designation for Vivet’s VTX-806
September 6, 2024
Lykos CEO to depart after FDA rejection, layoffs
September 6, 2024
Regulations
Regulatory Update — Week of Sept. 2, 2024
propharmanews
-
September 7, 2024
BioPharma
Judge orders J&J to pay Auris investors more than $1B for merger violations
propharmanews
-
September 7, 2024
Pharmaceuticals
Cloud moment – PharmaTimes
propharmanews
-
September 6, 2024
LATEST ARTICLES
Regulations
Regulatory Update — Week of Sept. 2, 2024
propharmanews
-
September 7, 2024
0
BioPharma
Judge orders J&J to pay Auris investors more than $1B for merger violations
propharmanews
-
September 7, 2024
0
Pharmaceuticals
Cloud moment – PharmaTimes
propharmanews
-
September 6, 2024
0
Pharmaceuticals
European Commission grants orphan drug designation for Vivet’s VTX-806
propharmanews
-
September 6, 2024
0
BioPharma
Lykos CEO to depart after FDA rejection, layoffs
propharmanews
-
September 6, 2024
0
Nutrition & Wellness
Seniq Trailmix Pants: Our Review, on and off the Trail
propharmanews
-
September 5, 2024
0
Regulations
Quick Notes: Medical Devices — Sept. 5, 2024
propharmanews
-
September 5, 2024
0
Healthcare
Steward loses money on Massachusetts hospital sales; CEO snubs Senate
propharmanews
-
September 5, 2024
0
MedTech
Abbott partners with maker of ‘bionic pancreas’
propharmanews
-
September 5, 2024
0
Pharmaceuticals
AMBLor prognostic melanoma biomarker receives UKCA Mark
propharmanews
-
September 5, 2024
0
1
2
3
...
17
Page 1 of 17
Most Popular
Regulatory Update — Week of Sept. 2, 2024
September 7, 2024
Judge orders J&J to pay Auris investors more than $1B for merger violations
September 7, 2024
Cloud moment – PharmaTimes
September 6, 2024
European Commission grants orphan drug designation for Vivet’s VTX-806
September 6, 2024
Load more
Recent Comments
AstraZeneca $20Bn Strategy - Pro Pharma News
on
Summit Therapeutics & AstraZeneca Shine at Major Cancer conference
China’s Generic Ozempic - Pro Pharma News
on
Ozempic’s Growing Generic Competition
Recent Comments